Analyst Recommendations

CIBC analyst issues OUTPERFORM recommendation for EMLAF on December 13, 2024 03:52PM ET. The previous analyst recommendation was Outperform.EMLAF was trading at $30.74 at issue of the analyst...

December 13, 2024   EMLAF 1.93%

CIBC analyst issues NEUTRAL recommendation for BIRDF on December 13, 2024 03:50PM ET. The previous analyst recommendation was Neutral.BIRDF was trading at $19.32 at issue of the analyst...

December 13, 2024   BIRDF 1.81%

CIBC analyst issues OUTPERFORM recommendation for AEGXF on December 13, 2024 03:47PM ET. The previous analyst recommendation was Outperform.AEGXF was trading at $19.03 at issue of the analyst...

December 13, 2024   AEGXF 2.97%

CIBC analyst issues OUTPERFORM recommendation for OCANF on December 13, 2024 03:52PM ET. The previous analyst recommendation was Outperform.OCANF was trading at $3.14 at issue of the analyst...

December 13, 2024   OCANF -0.58%

BMO Capital analyst issues OUTPERFORM recommendation for PBA on December 13, 2024 03:38PM ET. The previous analyst recommendation was Outperform.PBA was trading at $38.97 at issue of the...

December 13, 2024   PBA 1.22%

CIBC analyst issues OUTPERFORM recommendation for STN on December 13, 2024 03:45PM ET. The previous analyst recommendation was Outperform.STN was trading at $84.52 at issue of the analyst...

December 13, 2024   STN -1.34%

CIBC analyst issues OUTPERFORM recommendation for WSPOF on December 13, 2024 03:43PM ET. The previous analyst recommendation was Outperform.WSPOF was trading at $179.785 at issue of the analyst...

December 13, 2024   WSPOF -1.59%

CIBC analyst issues OUTPERFORM recommendation for SNCAF on December 13, 2024 03:49PM ET. The previous analyst recommendation was Outperform.SNCAF was trading at $52.33 at issue of the analyst...

December 13, 2024   SNCAF -0.77%

RBC Capital analyst issues SECTOR PERFORM recommendation for EMLAF on December 13, 2024 03:58PM ET. The previous analyst recommendation was Sector Perform.EMLAF was trading at $30.74 at issue...

December 13, 2024   EMLAF 1.93%

Raymond James analyst issues OUTPERFORM recommendation for CVE on December 13, 2024 04:04PM ET. The previous analyst recommendation was Outperform.CVE was trading at $15.12 at issue of the...

December 13, 2024   CVE 3.17%